NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Garber Alan M
Filed:
2026-04-17
AccNo:
0000875320-26-000159
Size:
5 KB
发布时间04/17 20:14 UTC
首次发现04/17 20:18 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 512 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0000875320-26-000159
Filing Date: 2026-04-17
Accepted: 2026-04-17 16:14:55
Documents: 1
Period of Report: 2026-04-15
VERTEX PHARMACEUTICALS INC / MA ( Issuer ) CIK : 0000875320 (see all company filings) EIN. : 043039129 | State of Incorp.: MA | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | FORM 4 | wk-form4_1776456893.html | 4
1 | FORM 4 | wk-form4_1776456893.xml | 4